Development and validation of an in-house real-time reverse-transcriptase polymerase chain reaction assay for sars-cov-2 omicron lineage subtyping between ba.1 and ba.2

HIGHLIGHTS

  • who: David Pham et al. from the Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health, Westmead, NSW, Australia Sydney Infectious Diseases Institute, The University of Sydney, Westmead, NSW, Australia have published the paper: Development and Validation of an In-House Real-Time Reverse-Transcriptase Polymerase Chain Reaction Assay for SARS-CoV-2 Omicron Lineage Subtyping between BA.1 and BA.2, in the Journal: Viruses 2022, 14, 1760. of 25/07/2022
  • what: The authors demonstrate the development and validation of a rapid and accurate RT-PCR assay targeting the S . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?